Skip to main content
Nicolas Palaskas, MD, Cardiology, Houston, TX

Nicolas Palaskas MD

Adult Congenital Heart Disease


Medical Resident, Medicine, Baylor College of Medicine

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Palaskas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Cardiovascular Disease, 2014 - 2017
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2011 - 2014
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2027
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2014 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2024 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • MD Anderson Research Highlights: SITC 2024 Special Edition
    MD Anderson Research Highlights: SITC 2024 Special EditionNovember 9th, 2024
  • Immune Checkpoint Inhibitors Linked to Range of Adverse Heart Effects
    Immune Checkpoint Inhibitors Linked to Range of Adverse Heart EffectsJuly 12th, 2022
  • Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
    Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceNovember 12th, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: